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background: Iron deficiency (ID) may be frequent in patients with chronic heart failure and can be improved with intravenous (IV) iron therapy; 
however, few data are available on ID status in acute decompensated heart failure (ADHF).
Methods: CardioFer is a multicenter, clinical study conducted at 46 sites in patients hospitalized for ADHF. ID (assessed in the first 72 h post 
admission) was defined according to the European Society of Cardiology Guidelines for 2012 as a serum ferritin <100 µg/mL (absolute ID) or a 
serum ferritin between 100 and 299 µg/mL with transferrin saturation <20% (functional ID). Anemia was defined as a haemoglobin concentration 
<13 g/dL in men and <12 g/dL in women.
results: Overall, 411 men (74.8 y ± 12.0 y) and 421 women (81.2 y ± 11.4 y) were evaluated. The main conditions associated with ADHF were 
atrial arrhythmia (25.2%), anemia (22.4%), diet deviation (15.7%), and pulmonary infection (16.1%). Only 35 (8.5%) men and 39 (9.3%) women 
received iron supplementation at the time of admission. The prevalence of anemia was 67.6% (95% confidence interval, 62.9%-72.1%) in men 
and 52.0% (47.1%-56.9%) in women, and that of ID was 68.6% (63.9%-73.1%) in men and 75.3% (70.9%-79.4%) in women. Absolute ID was the 
most common type of ID, with a prevalence of 40.6% (35.9%-45.6%) in men and 48.9% (44.1%-53.8%) in women. In patients without anemia, ID 
prevalence was 57.1% (48.3%-65.7%) in men and 78.7% (72.4%-84.2%) in women. There was no significant relationship in either men or women 
between anemia or ID status with age, New York Heart Association functional classification, B-type natriuretic peptide level, or left ventricular 
ejection fraction.
conclusion: ID is very common in patients admitted for ADHF, even in patients without anemia. ID before ADHF is underdiagnosed and 
undertreated.
